CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Income Statement [Abstract]
Net Sales	$ 69,258,000	$ 101,489,000
Cost of Sales	57,563,000	84,005,000
Gross Profit	11,695,000	17,484,000
Research and Product Development	0	19,000
Selling and Marketing	2,354,000	2,749,000
General and Administrative	14,032,000	14,108,000
Operating (Loss) Income	(4,691,000)	608,000
Other Income (Expense):
Realized Gain on Available-for-Sale Investments	267,000	74,000
Interest Expense	(1,124,000)	(1,254,000)
Interest Income	234,000	92,000
Total Other Expense, net	(623,000)	(1,088,000)
Net Loss	$ (5,314,000)	$ (480,000)
Net Loss Per Share Attributable to Common Stockholders - Basic (in dollars per share)	$ (0.15)	$ (0.03)
Net Loss Per Share Attributable to Common Stockholders - Diluted (in dollars per share)	$ (0.15)	$ (0.03)
Weighted Average Number of Shares of Common Stock Outstanding - Basic (in shares)	35,974,231	31,058,539
Weighted Average Number of Shares of Common Stock Outstanding - Diluted (in shares)	35,974,231	31,058,539